Media
Press Releases
2008
SynDevRx Establishes SAB Jan.8
New Oral Angiogenesis Inhibitor Offers Potential Nontoxic Therapy For A Wide Range Of Cancers
Executive Summary
Click here for the most recent SynDevRx Executive Summary.
One Broadway, 14th Floor, Cambridge MA 02142 Tel: 617.401.3110
